Stem Cells and Biotherapy Engineering Research Center of Henan, National Joint Engineering Laboratory of Stem Cells and Biotherapy, School of Life Science and Technology, Xinxiang Medical University, Xinxiang, China.
Stem Cells and Biotherapy Engineering Research Center of Henan, National Joint Engineering Laboratory of Stem Cells and Biotherapy, School of Life Science and Technology, Xinxiang Medical University, Xinxiang, China; Translational Neurodegeneration Section "Albrecht-Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, Rostock, Germany.
Biochim Biophys Acta Mol Basis Dis. 2024 Dec;1870(8):167478. doi: 10.1016/j.bbadis.2024.167478. Epub 2024 Aug 22.
Niemann-Pick disease Type C (NPC) is a neurodegenerative disease mainly caused by the mutation in NPC1 gene, leading to massive accumulation of unesterified cholesterol in the late endosome/lysosome of cells. Impaired phenotype of microglia is a hallmark in Npc1 mutant mice (Npc1 mice). However, the mechanism of Npc1 in regulating microglial function is still unclear. Here, we showed that the reactive microglia in the neonatal Npc1 mice indicated by the increased lysosome protein CD68 and phagocytic activity were associated with disrupted TREM2-mTOR signaling in microglia. Furthermore, in Npc1-deficient BV2 cells, genetic deletion of Trem2 partially restored microglial function, probably via restored mTOR signaling. Taken together, our findings indicated that loss of Npc1 in microglia caused changes of their morphologies and the impairment of lysosomal function, which were linked to the TREM2-mTOR signaling pathway.
尼曼-匹克病 C 型(NPC)是一种神经退行性疾病,主要由 NPC1 基因突变引起,导致细胞内晚期内体/溶酶体中未酯化胆固醇的大量积累。在 Npc1 突变小鼠(Npc1 小鼠)中,小胶质细胞的损伤表型是一个标志。然而,Npc1 调节小胶质细胞功能的机制尚不清楚。在这里,我们发现新生 Npc1 小鼠中的反应性小胶质细胞通过增加溶酶体蛋白 CD68 和吞噬活性来表示,与小胶质细胞中 TREM2-mTOR 信号的破坏有关。此外,在 Npc1 缺陷的 BV2 细胞中,Trem2 的基因缺失部分恢复了小胶质细胞的功能,可能是通过恢复 mTOR 信号。总之,我们的研究结果表明,小胶质细胞中 Npc1 的缺失导致其形态和溶酶体功能的改变,这与 TREM2-mTOR 信号通路有关。